JP4083431B2 - ３，３−ジフェニルプロピルアミン類の新規誘導体の安定な塩 - Google Patents

３，３−ジフェニルプロピルアミン類の新規誘導体の安定な塩 Download PDF

Info

Publication number
JP4083431B2
JP4083431B2 JP2001537950A JP2001537950A JP4083431B2 JP 4083431 B2 JP4083431 B2 JP 4083431B2 JP 2001537950 A JP2001537950 A JP 2001537950A JP 2001537950 A JP2001537950 A JP 2001537950A JP 4083431 B2 JP4083431 B2 JP 4083431B2
Authority
JP
Japan
Prior art keywords
acid
diisopropylamino
phenyl
phenylpropyl
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP2001537950A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003514018A (ja
Inventor
メーゼ、クラウス
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UCB Pharma GmbH
Original Assignee
Schwarz Pharma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7929277&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JP4083431(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schwarz Pharma AG filed Critical Schwarz Pharma AG
Publication of JP2003514018A publication Critical patent/JP2003514018A/ja
Application granted granted Critical
Publication of JP4083431B2 publication Critical patent/JP4083431B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C219/00—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C219/26—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/46—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C215/48—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups
    • C07C215/54—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups linked by carbon chains having at least three carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/06—Anti-spasmodics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C219/00—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C219/26—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C219/28—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton having amino groups bound to acyclic carbon atoms of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/38—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to acyclic carbon atoms and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Catalysts (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Luminescent Compositions (AREA)
  • Detergent Compositions (AREA)
JP2001537950A 1999-11-16 2000-11-15 ３，３−ジフェニルプロピルアミン類の新規誘導体の安定な塩 Expired - Lifetime JP4083431B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19955190.1 1999-11-16
DE19955190A DE19955190A1 (de) 1999-11-16 1999-11-16 Stabile Salze neuartiger Derivate von 3,3-Diphenylpropylaminen
PCT/EP2000/011309 WO2001035957A1 (de) 1999-11-16 2000-11-15 Stabile salze neuartiger derivate von 3,3-diphenylpropylaminen

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2007042774A Division JP2007137895A (ja) 1999-11-16 2007-02-22 ３，３−ジフェニルプロピルアミン類の新規誘導体の安定な塩

Publications (2)

Publication Number Publication Date
JP2003514018A JP2003514018A (ja) 2003-04-15
JP4083431B2 true JP4083431B2 (ja) 2008-04-30

Family

ID=7929277

Family Applications (6)

Application Number Title Priority Date Filing Date
JP2001537950A Expired - Lifetime JP4083431B2 (ja) 1999-11-16 2000-11-15 ３，３−ジフェニルプロピルアミン類の新規誘導体の安定な塩
JP2007042774A Pending JP2007137895A (ja) 1999-11-16 2007-02-22 ３，３−ジフェニルプロピルアミン類の新規誘導体の安定な塩
JP2010098844A Expired - Lifetime JP5650924B2 (ja) 1999-11-16 2010-04-22 ３，３−ジフェニルプロピルアミン類の新規誘導体の安定な塩
JP2010098845A Expired - Lifetime JP5503393B2 (ja) 1999-11-16 2010-04-22 ３，３−ジフェニルプロピルアミン類の新規誘導体の安定な塩
JP2011096911A Expired - Lifetime JP5290351B2 (ja) 1999-11-16 2011-04-25 ３，３−ジフェニルプロピルアミン類の新規誘導体の安定な塩
JP2013229622A Expired - Lifetime JP5717824B2 (ja) 1999-11-16 2013-11-05 ３，３−ジフェニルプロピルアミン類の新規誘導体の安定な塩

Family Applications After (5)

Application Number Title Priority Date Filing Date
JP2007042774A Pending JP2007137895A (ja) 1999-11-16 2007-02-22 ３，３−ジフェニルプロピルアミン類の新規誘導体の安定な塩
JP2010098844A Expired - Lifetime JP5650924B2 (ja) 1999-11-16 2010-04-22 ３，３−ジフェニルプロピルアミン類の新規誘導体の安定な塩
JP2010098845A Expired - Lifetime JP5503393B2 (ja) 1999-11-16 2010-04-22 ３，３−ジフェニルプロピルアミン類の新規誘導体の安定な塩
JP2011096911A Expired - Lifetime JP5290351B2 (ja) 1999-11-16 2011-04-25 ３，３−ジフェニルプロピルアミン類の新規誘導体の安定な塩
JP2013229622A Expired - Lifetime JP5717824B2 (ja) 1999-11-16 2013-11-05 ３，３−ジフェニルプロピルアミン類の新規誘導体の安定な塩

Country Status (30)

Country Link
US (1) US6858650B1 (cg-RX-API-DMAC7.html)
EP (3) EP1690536B1 (cg-RX-API-DMAC7.html)
JP (6) JP4083431B2 (cg-RX-API-DMAC7.html)
KR (2) KR100536095B1 (cg-RX-API-DMAC7.html)
CN (1) CN1215045C (cg-RX-API-DMAC7.html)
AT (3) ATE337293T1 (cg-RX-API-DMAC7.html)
AU (1) AU778132B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0015610C1 (cg-RX-API-DMAC7.html)
CA (1) CA2389749C (cg-RX-API-DMAC7.html)
CY (2) CY1106204T1 (cg-RX-API-DMAC7.html)
CZ (2) CZ302967B6 (cg-RX-API-DMAC7.html)
DE (5) DE29923134U1 (cg-RX-API-DMAC7.html)
DK (3) DK1690536T3 (cg-RX-API-DMAC7.html)
EA (1) EA005588B1 (cg-RX-API-DMAC7.html)
ES (3) ES2236032T7 (cg-RX-API-DMAC7.html)
GE (1) GEP20084430B (cg-RX-API-DMAC7.html)
HK (1) HK1045148B (cg-RX-API-DMAC7.html)
HU (2) HU228197B1 (cg-RX-API-DMAC7.html)
IL (2) IL149567A0 (cg-RX-API-DMAC7.html)
IS (2) IS2124B (cg-RX-API-DMAC7.html)
MX (1) MXPA02004603A (cg-RX-API-DMAC7.html)
NO (2) NO323920B1 (cg-RX-API-DMAC7.html)
NZ (1) NZ519230A (cg-RX-API-DMAC7.html)
PL (1) PL201422B1 (cg-RX-API-DMAC7.html)
PT (3) PT1481964E (cg-RX-API-DMAC7.html)
SI (3) SI1230209T1 (cg-RX-API-DMAC7.html)
SK (3) SK287430B6 (cg-RX-API-DMAC7.html)
UA (2) UA73324C2 (cg-RX-API-DMAC7.html)
WO (1) WO2001035957A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200203315B (cg-RX-API-DMAC7.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007137895A (ja) * 1999-11-16 2007-06-07 Schwarz Pharma Ag ３，３−ジフェニルプロピルアミン類の新規誘導体の安定な塩

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0957073A1 (en) * 1998-05-12 1999-11-17 Schwarz Pharma Ag Novel derivatives of 3,3-diphenylpropylamines
DE10028443C1 (de) * 2000-06-14 2002-05-29 Sanol Arznei Schwarz Gmbh Verfahren zur Herstellung von 3,3-Diarylpropylaminen, (R,S)- und (R)-4-Phenyl-2-chromanon-6-carbonsäure sowie (R)-4-Phenyl-2-chromanon-carbonsäure-cinchonidinsalz und deren Verwendung zur Herstellung eines rechtsdrehenden Hydroxybenzylalkohols und von pharmazeutischen Zusammensetzungen
DE10315917A1 (de) * 2003-04-08 2004-11-18 Schwarz Pharma Ag Hochreine Basen von 3,3-Diphenylpropylaminmonoestern
DE10315878B4 (de) * 2003-04-08 2009-06-04 Schwarz Pharma Ag Vorrichtung zur transdermalen Verabreichung von Fesoterodin und Verwendung
WO2005012227A2 (en) * 2003-08-05 2005-02-10 Ranbaxy Laboratories Limited Process for preparation of 2-(3-diisopropylamino-1-phenylpropyl)-4-hydroxymethyl-phenol, a metabolite of tolterodine
ES2235648B1 (es) * 2003-12-22 2006-11-01 Ragactives, S.L. Procedimiento para la obtencion de tolterodina.
US8034823B2 (en) * 2005-02-22 2011-10-11 Savvipharm Inc Method of increasing drug oral bioavailability and compositions of less toxic orotate salts
KR100647068B1 (ko) 2005-09-15 2006-11-23 하나제약 주식회사 라세믹ｎ,ｎ-디이소프로필-3-(2-히드록시-5-메틸페닐)-3-페닐프로판아민의 제조방법
PL2029567T3 (pl) * 2006-05-24 2011-01-31 Pfizer Ltd Sposób wytwarzania pochodnych benzopiran-2-olu
EP1862449A1 (en) * 2006-05-31 2007-12-05 Schwarz Pharma Ltd. A shortened synthesis of substituted hydroxymethyl phenols
AU2007267371B2 (en) * 2006-05-31 2012-09-20 Schwarz Pharma Ltd. New synthesis of substituted hydroxymethyl phenols
IES20060424A2 (en) * 2006-06-08 2007-10-31 Schwarz Pharma Ltd Accelerated synthesis of (3-Diisopropylamino-1-phenylpropyl)-4-(hydroxymethyl)phenol and its phenolic monoesters
BRPI0712865B1 (pt) 2006-06-09 2021-08-17 Schwarz Pharma Ag Composição farmacêutica estabilizada compreendendo fesoterodina, método para preparação da mesma e uso de uma substância
US7807715B2 (en) 2006-06-09 2010-10-05 Ucb Pharma Gmbh Pharmaceutical compositions comprising fesoterodine
EP2004592B1 (en) 2006-06-09 2010-08-11 Schwarz Pharma Ltd. Synthesis of phenolic esters of hydroxymethyl phenols
IES20060435A2 (en) 2006-06-12 2007-12-12 Schwarz Pharma Ltd Shortened synthesis using paraformaldehyde or trioxane
EA018376B1 (ru) 2006-06-12 2013-07-30 Шварц Фарма Аг Новые хиральные промежуточные продукты, способ их получения и их применение в производстве толтеродина, фезотеродина или их активных метаболитов
WO2009037569A2 (en) * 2007-09-21 2009-03-26 Actavis Group Ptc Ehf An improved process for the preparation of fesoterodine
US20100297241A1 (en) * 2007-10-01 2010-11-25 Actavis Group Ptc Ehf Amorphous Fesoterodine Fumarate
EP2294047A2 (en) * 2008-04-04 2011-03-16 Actavis Group PTC EHF Novel mandelate salt of fesoterodine
US20110171274A1 (en) * 2008-07-21 2011-07-14 Actavis Group Ptc Ehf Fesoterodine Substantially Free of Dehydroxy Impurity
IT1392082B1 (it) * 2008-12-10 2012-02-09 Chemi Spa Nuove forme solide della fesoterodina fumarato
KR20120014583A (ko) 2009-05-11 2012-02-17 라티오팜 게엠베하 타르타르산 염 형태의 데스페소테로딘
IT1394219B1 (it) 2009-05-15 2012-06-01 Chemi Spa Metodo di preparazione di fesoterodina fumarato di elevata purezza.
IT1394217B1 (it) * 2009-05-15 2012-06-01 Chemi Spa Metodo di preparazione di fesoterodina e/o fesoterodina fumarato.
WO2011029005A1 (en) 2009-09-03 2011-03-10 Teva Gyogyszergyar Zartkoruen Mukodo Reszvenytarsasag Crystalline forms of fesoterodine fumarate and fesoterodine base
IT1396373B1 (it) * 2009-10-29 2012-11-19 Dipharma Francis Srl Procedimento per la preparazione di fesoterodina.
EP2316432A1 (de) 2009-10-30 2011-05-04 ratiopharm GmbH Zusammensetzung enthaltend Fesoterodin und Ballaststoffe
US20110124903A1 (en) * 2009-11-20 2011-05-26 Actavis Group Ptc Ehf Solid state forms of fesoterodine intermediates
IT1397521B1 (it) * 2009-12-21 2013-01-16 Dipharma Francis Srl Procedimento per la preparazione di fesoterodina con un basso contenuto di impurezze.
IT1397920B1 (it) * 2010-02-08 2013-02-04 Dipharma Francis Srl Forma cristallina di fesoterodina fumarato e procedimento per la sua preparazione
EP2549985A1 (en) 2010-03-22 2013-01-30 Cadila Healthcare Limited Stable pharmaceutical compositions comprising fesoterodine
JP5812500B2 (ja) 2010-04-30 2015-11-17 メルク・シャープ・エンド・ドーム・コーポレイション 新規なβ３アドレナリン作動性受容体アゴニスト
US20110282094A1 (en) * 2010-05-11 2011-11-17 Intas Pharmaceuticals Limited Process for preparation of phenolic monoesters of hydroxymethyl phenols
WO2011145019A1 (en) * 2010-05-17 2011-11-24 Orchid Chemicals And Pharmaceuticals Limited Improved process for diphenylpropylamine derivatives
IT1401451B1 (it) 2010-06-10 2013-07-26 Chemi Spa Nuovo processo di preparazione di 2-idrossi-4-fenil-3,4-diidro-2h-cromen-6-il-metanolo e (r)-2-[3-(diisopropilammino)-1-fenilpropil]-4-(idrossimetil)fenolo.
WO2011158257A1 (en) 2010-06-18 2011-12-22 Panacea Biotec Ltd Preparation process of fesoterodine and intermediates
WO2012025941A2 (en) 2010-08-25 2012-03-01 Cadila Healthcare Limited Processes for the preparation of fesoterodine
IT1403094B1 (it) 2010-12-09 2013-10-04 Dipharma Francis Srl Procedimento per la preparazione di fesoterodina o un suo sale
WO2012098560A2 (en) * 2011-01-17 2012-07-26 Msn Laboratories Limited Process for the preparation of muscarinic receptor antagonist
TWI590821B (zh) 2011-01-18 2017-07-11 輝瑞有限公司 固體分子分散液
EP2508175A1 (en) 2011-04-08 2012-10-10 LEK Pharmaceuticals d.d. Pharmaceutical composition comprising fesoterodine or a salt or a solvate thereof
EP2508173A1 (en) 2011-04-08 2012-10-10 LEK Pharmaceuticals d.d. Stabilized pharmaceutical composition comprising fesoterodine
WO2013113946A2 (en) 2012-05-04 2013-08-08 Crystal Pharma, S.A.U. Process for the preparation of optically active 3,3-diphenylpropylamines
ITMI20121232A1 (it) 2012-07-16 2014-01-17 Cambrex Profarmaco Milano Srl Procedimento per la preparazione di 2-(3-n,n-diisopropilamino-1-fenilpropil)-4-idrossimetil-fenolo e suoi derivati
TR201721437A2 (tr) 2017-12-25 2019-07-22 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Fesoterodi̇ni̇n modi̇fi̇ye salim sağlayan formülasyonlari
WO2022090235A1 (en) * 2020-10-27 2022-05-05 Wella Germany Gmbh 2-methoxymethyl-p-phenylenediamine in cosmetic grade quality

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL233786A1 (cg-RX-API-DMAC7.html) * 1980-11-14 1982-05-24 Lilly Co Eli
IL66831A0 (en) * 1981-10-05 1982-12-31 Kefalas As Indane derivatives
SE8800207D0 (sv) * 1988-01-22 1988-01-22 Kabivitrum Ab Nya aminer, deras anvendning och framstellning
IE910752A1 (en) * 1990-03-08 1991-09-11 Fujisawa Pharmaceutical Co A novel substituted-amine compound and a process for the¹preparation thereof
JPH0483431A (ja) * 1990-07-26 1992-03-17 Seiko Epson Corp 選択呼出受信機
SE9203318D0 (sv) 1992-11-06 1992-11-06 Kabi Pharmacia Ab Novel 3,3-diphenylpropylamines, their use and preparation
SE9701144D0 (sv) * 1997-03-27 1997-03-27 Pharmacia & Upjohn Ab Novel compounds, their use and preparation
EP0957073A1 (en) 1998-05-12 1999-11-17 Schwarz Pharma Ag Novel derivatives of 3,3-diphenylpropylamines
DE29923134U1 (de) * 1999-11-16 2000-06-29 Schwarz Pharma Ag, 40789 Monheim Stabile Salze neuartiger Derviate von 3,3-Diphenylpropylaminen

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007137895A (ja) * 1999-11-16 2007-06-07 Schwarz Pharma Ag ３，３−ジフェニルプロピルアミン類の新規誘導体の安定な塩
JP2010180242A (ja) * 1999-11-16 2010-08-19 Ucb Pharma Gmbh ３，３−ジフェニルプロピルアミン類の新規誘導体の安定な塩
JP2010180243A (ja) * 1999-11-16 2010-08-19 Ucb Pharma Gmbh ３，３−ジフェニルプロピルアミン類の新規誘導体の安定な塩

Also Published As

Publication number Publication date
HU227608B1 (en) 2011-09-28
SI1481964T1 (sl) 2006-12-31
PT1481964E (pt) 2006-12-29
SK6572002A3 (en) 2002-12-03
UA73324C2 (uk) 2005-07-15
JP5717824B2 (ja) 2015-05-13
KR20020059744A (ko) 2002-07-13
HK1067114A1 (en) 2005-04-01
EP1481964A1 (de) 2004-12-01
HU0900587D0 (en) 2009-11-30
GEP20084430B (cg-RX-API-DMAC7.html) 2008-07-25
EP1230209B1 (de) 2005-01-12
BRPI0015610C1 (pt) 2021-05-25
CY1106204T1 (el) 2011-06-08
EA005588B1 (ru) 2005-04-28
KR20050100711A (ko) 2005-10-19
EP1690536B1 (de) 2008-05-14
SK288185B6 (sk) 2014-04-02
CN1390194A (zh) 2003-01-08
ES2236032T7 (es) 2012-06-14
NO323920B1 (no) 2007-07-23
CA2389749C (en) 2009-03-31
ATE395056T1 (de) 2008-05-15
DK1230209T3 (da) 2005-05-30
BR0015610B8 (pt) 2017-10-31
IS2124B (is) 2006-07-14
DE19955190A1 (de) 2001-06-21
SK288384B6 (sk) 2016-08-01
JP5290351B2 (ja) 2013-09-18
EP1690536A3 (de) 2006-08-23
EA200200511A1 (ru) 2002-10-31
EP1481964B1 (de) 2006-08-23
IS6351A (is) 2002-04-19
PL201422B1 (pl) 2009-04-30
SK287430B6 (sk) 2010-09-07
CN1215045C (zh) 2005-08-17
HU228197B1 (en) 2013-01-28
SI1690536T1 (sl) 2008-08-31
KR100536095B1 (ko) 2005-12-12
IL149567A (en) 2007-08-19
NO332637B1 (no) 2012-11-26
CZ302967B6 (cs) 2012-01-25
IS2673B (is) 2010-09-15
ATE337293T1 (de) 2006-09-15
JP2007137895A (ja) 2007-06-07
HK1045148B (zh) 2005-05-06
HUP0204034A2 (hu) 2003-03-28
ES2270240T3 (es) 2007-04-01
HK1095736A1 (en) 2007-05-18
DK1690536T3 (da) 2008-09-01
NZ519230A (en) 2004-11-26
PT1690536E (pt) 2008-07-14
NO20065380L (no) 2002-05-15
US6858650B1 (en) 2005-02-22
EP1230209B3 (de) 2011-10-05
JP5650924B2 (ja) 2015-01-07
HUP0204034A3 (en) 2004-12-28
JP2014111589A (ja) 2014-06-19
WO2001035957A8 (de) 2001-06-21
MXPA02004603A (es) 2004-09-10
ZA200203315B (en) 2003-09-23
NO20022314L (no) 2002-05-15
UA77322C2 (en) 2006-11-15
EP1690536A2 (de) 2006-08-16
JP2003514018A (ja) 2003-04-15
AU778132B2 (en) 2004-11-18
BR0015610A (pt) 2002-07-30
SI1230209T1 (en) 2005-06-30
ATE286872T1 (de) 2005-01-15
JP2011148824A (ja) 2011-08-04
NO20022314D0 (no) 2002-05-15
PT1230209E (pt) 2005-05-31
WO2001035957A3 (de) 2001-12-27
AU2666701A (en) 2001-05-30
HUP0900587A3 (en) 2010-04-28
EP1230209A2 (de) 2002-08-14
CZ302497B6 (cs) 2011-06-15
JP2010180242A (ja) 2010-08-19
HK1045148A1 (en) 2002-11-15
DE29923134U1 (de) 2000-06-29
CA2389749A1 (en) 2001-05-25
DE50013365D1 (de) 2006-10-05
JP5503393B2 (ja) 2014-05-28
DE50015163D1 (de) 2008-06-26
ES2236032T3 (es) 2005-07-16
CY1110389T1 (el) 2015-04-29
KR100563149B1 (ko) 2006-03-21
WO2001035957A1 (de) 2001-05-25
DK1481964T3 (da) 2006-11-27
ES2303708T3 (es) 2008-08-16
IL149567A0 (en) 2002-11-10
JP2010180243A (ja) 2010-08-19
BRPI0015610B1 (pt) 2016-04-19
DE50009239D1 (de) 2005-02-17
PL356766A1 (en) 2004-07-12
CZ20021343A3 (cs) 2002-09-11
IS8382A (is) 2006-03-29

Similar Documents

Publication Publication Date Title
JP4083431B2 (ja) ３，３−ジフェニルプロピルアミン類の新規誘導体の安定な塩
KR100486394B1 (ko) 3,3-디페닐-프로필아민의 신규한 유도체의 안정한 염
HK1067114B (en) Stable salts of novel derivatives of 3,3-diphenylpropylamines

Legal Events

Date Code Title Description
A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20060822

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20061122

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20061211

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20070222

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20070508

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20070808

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20070815

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20071108

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20071211

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20071214

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20080129

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20080213

R150 Certificate of patent or registration of utility model

Ref document number: 4083431

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110222

Year of fee payment: 3

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120222

Year of fee payment: 4

S533 Written request for registration of change of name

Free format text: JAPANESE INTERMEDIATE CODE: R313533

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120222

Year of fee payment: 4

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

RD02 Notification of acceptance of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: R3D02

S201 Request for registration of exclusive licence

Free format text: JAPANESE INTERMEDIATE CODE: R314201

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120222

Year of fee payment: 4

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120222

Year of fee payment: 4

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130222

Year of fee payment: 5

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130222

Year of fee payment: 5

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20140222

Year of fee payment: 6

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20140222

Year of fee payment: 6

R153 Grant of patent term extension

Free format text: JAPANESE INTERMEDIATE CODE: R153

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

EXPY Cancellation because of completion of term